ARIF PATNI: Open Payments
NPI 1033116934 · BUFORD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 33 payments from 13 companies in 2025. Trend: 2023 $700 · 2024 $512 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $251 |
| Corcept Therapeutics | 3 | $84 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Lilly USA, LLC | 4 | $68 |
| Inspire Medical Systems, Inc. | 2 | $66 |
| ABBVIE INC. | 3 | $44 |
| Dexcom, Inc. | 2 | $38 |
| Lundbeck LLC | 1 | $31 |
| Corium, LLC | 1 | $24 |
| Abbott Laboratories | 1 | $19 |
Products named: Ozempic, Korlym, Wegovy, MOUNJARO, INSPIRE, Dexcom G6 Transmitter, BREZTRI, REXULTI.
Industry payments across GA — which companies pay providers there.
